Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,755.50
Bid: 1,755.00
Ask: 1,755.50
Change: -0.50 (-0.03%)
Spread: 0.50 (0.028%)
Open: 1,743.50
High: 1,759.00
Low: 1,740.50
Prev. Close: 1,756.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Stocks rise but markets cautious ahead of Fed decision

Wed, 30th Apr 2014 11:53

- Markets cautious ahead of FOMC outcome- Eurozone inflation picks up but misses consensus- Heritage Oil jumps on takeover offer- Shell and Tullow lead markets highertechMARK 2,775.59 -0.56%FTSE 100 6,776.83 +0.10%FTSE 250 15,813.39 -0.52%UK stocks were trading slightly higher on Wednesday but were rangebound in morning trade after markets hit an eight-week high the previous session.A raft of economic data and corporate earnings were keep traders busy today, while nervousness ahead of this evening's policy decision by the Federal Reserve prompted many to scale back risk.The Federal Open Market Committee begun its two-day policy meeting yesterday and is widely expected to continue tapering its asset purchase programme by $10bn each meeting. This will bring the monthly stock of bond buying down from $55bn to $45bn."It's very unlikely that they'd change this amount or announce anything different when there's no accompanying press conference. It would cause unnecessary panic in the markets, which the Fed has tried to avoid when possible," said Market Analyst Craig Erlam from Alpari.The FTSE 100 was trading 0.1% higher at 6,777 by midday after closing at 6,769.91 on Tuesday afternoon, its highest finish since March 6th.In economic news this morning, Eurozone inflation rose less than expected in April, according to the flash estimate published this morning by Eurostat. The annual rate of consumer price inflation rose to 0.7% this month after prices rose by 0.5% in March. However, this compared to the consensus estimate for a 0.8% rise. US stock futures were pointing to a lower start on Wall Street later on ahead of upcoming mortgage applications data and the ADP employment report, as well as a reading of US economic growth for the first quarter. Heritage Oil jumps after takeover offerHeritage Oil shares surged this morning after Energy Investments Global offer 320p a share to take over the company, some 25% above yesterday's closing price. The offer values the company at £924m. Heritage also announced today that profits more than doubled in 2013.Oil major Royal Dutch Shell rose strongly despite saying that first-quarter underlying earnings fell by 3%, which exclude £2.9bn of impairments in its Downstream division.Sector peer Tullow also gained after saying it is on track to meet its 2014 production guidance following a good performance since the start of the year.Rolls-Royce, the power systems group, was also higher after confirming media speculation that it is in talks with German engineer Siemens about the possible sale of its energy gas turbine and compressor division.High street retail giant Next was swinging between gains and losses despite lifting its guidance for sales and profits this year after a strong performance in the first quarter. The company also announced that it would pay a special dividend and raise the limit of its share buyback.Heading the other way was insurer Standard Life after underwhelming with a 1.5% rise in assets under administration in the first quarter.GlaxoSmithKline was in the red despite meeting expectations with a 2% rise in constant-currency core earnings per share to 21p. Revenues however declined by 2% to £5.6bn.Admiral fell after going ex-dividend, along with others including ITV, Croda, Cobham, G4S, Ferrexpo, Tesco, Reed Elsevier, Travis Perkins and Weir.FTSE 100 - RisersRoyal Dutch Shell 'B' (RDSB) 2,547.00p +4.77%Royal Dutch Shell 'A' (RDSA) 2,372.50p +4.06%Barratt Developments (BDEV) 364.50p +3.76%WPP (WPP) 1,264.00p +2.27%Capita (CPI) 1,076.00p +1.99%Tullow Oil (TLW) 881.00p +1.79%Rolls-Royce Holdings (RR.) 1,039.00p +1.76%BG Group (BG.) 1,199.50p +1.61%Severn Trent (SVT) 1,853.00p +1.59%Shire Plc (SHP) 3,299.00p +1.10%FTSE 100 - FallersAdmiral Group (ADM) 1,390.00p -3.61%Tesco (TSCO) 293.05p -3.38%Hargreaves Lansdown (HL.) 1,161.00p -2.19%Reed Elsevier (REL) 864.50p -2.10%British American Tobacco (BATS) 3,415.00p -2.06%William Hill (WMH) 340.10p -2.04%GlaxoSmithKline (GSK) 1,632.00p -2.01%ITV (ITV) 180.00p -2.01%Imperial Tobacco Group (IMT) 2,556.00p -1.88%Weir Group (WEIR) 2,679.00p -1.83%FTSE 250 - RisersHeritage Oil (HOIL) 313.40p +22.61%Aveva Group (AVV) 2,097.00p +7.26%Ophir Energy (OPHR) 265.00p +5.49%Afren (AFR) 159.00p +3.72%Playtech (PTEC) 654.50p +2.51%Cairn Energy (CNE) 183.70p +1.94%Bellway (BWY) 1,424.00p +1.79%Premier Oil (PMO) 343.00p +1.72%Taylor Wimpey (TW.) 104.10p +1.46%Soco International (SIA) 424.30p +1.39%FTSE 250 - FallersCSR (CSR) 604.00p -5.85%Supergroup (SGP) 1,317.00p -4.08%UBM (UBM) 646.00p -3.94%Hunting (HTG) 850.00p -3.57%SIG (SHI) 192.00p -3.57%Kazakhmys (KAZ) 228.60p -3.54%Elementis (ELM) 275.70p -3.47%Petra Diamonds Ltd.(DI) (PDL) 162.20p -3.45%IP Group (IPO) 174.10p -3.28%Cranswick (CWK) 1,197.00p -3.23%BC
More News
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more
26 Oct 2023 09:19

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.

Read more
26 Oct 2023 07:02

GSK HIV injection regimen gets approval in China

(Sharecast News) - GSK announced on Thursday that its majority-owned HIV specialist subsidiary ViiV has received approval from the National Medical Products Administration (NMPA) of China for an injection regimen.

Read more
25 Oct 2023 16:01

UK earnings, trading statements calendar - next 7 days

Thursday 26 October 
Bank of Ireland Group PLCTrading Statement
Bloomsbury Publishing PLCHalf Year Results
Botswana Diamonds PLCTrading Statement
C&C Group PLCHalf Year Results
e-Therapeutics PLCHalf Year Results
Financials Acquisition CorpTrading Statement
GCP Infrastructure Investments LtdTrading Statement
HarbourVest Global Private Equity LtdHalf Year Results
Hummingbird Resources PLCTrading Statement
Hunting PLCTrading Statement
Inchcape PLCTrading Statement
International Personal Finance PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Renishaw PLCTrading Statement
Standard Chartered PLCQ3 Results
Unilever PLCTrading Statement
WPP PLCTrading Statement
Friday 27 October 
International Consolidated Airlines Group SAQ3 Results
NatWest Group PLCQ3 Results
Monday 30 October 
Airtel Africa PLCHalf Year Results
Computacenter PLCTrading Statement
Glencore PLCTrading Statement
HSBC Holdings PLCQ3 Results
Lok'n Store Group PLCFull Year Results
Pearson PLCTrading Statement
Tuesday 31 October 
BP PLCQ3 Results
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCFull Year Results
Georgia Capital PLCQ3 Results
Grit Real Estate Income Group LtdFull Year Results
RHI Magnesita NVTrading Statement
Spectris PLCQ3 Results
TP ICAP Group PLCTrading Statement
UP Global Sourcing Holdings PLCFull Year Results
Wednesday 1 November 
Asos PLCFull Year Results
Aston Martin Lagonda Global Holdings PLCQ3 Results
Beximco Pharmaceuticals LtdFull Year Results
GSK PLCQ3 Results
Next PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Weir Group PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
25 Oct 2023 09:35

GSK says RSV jab shows promising response in adults aged 50 to 59

(Alliance News) - GSK PLC on Wednesday said a trial found its respiratory syncytial virus vaccine Arexy delivered an immune response in adults aged 50 to 59.

Read more
25 Oct 2023 07:27

GSK hails success in US RSV vaccine trial

(Sharecast News) - Pharma giant GSK has announced positive preliminary results from a trial of its Arexvy vaccine to treatment respiratory syncytial virus (RSV) disease for a younger patient population in the US.

Read more
16 Oct 2023 08:09

TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer

(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer.

Read more
16 Oct 2023 07:44

LONDON BRIEFING: Hipgnosis pulls interim dividend on lower royalties

(Alliance News) - The FTSE 100 is likely to open higher on Monday, benefitting from higher oil and gas prices, while fears of escalating regional conflict in the Middle East damp risk sentiment elsewhere.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.